Linganisha mbinu

	MDS-UPDRS	MSFC: Kipimo Jumuishi cha Utendaji Kazi wa Sclerosis Nyingi
Nyanja	Neurolojia	Neurolojia
Familia	Process / pipeline	Process / pipeline
Mwaka wa asili	2008	1999
Mwanzilishi	Christopher G. Goetz and Movement Disorder Society	Gary Cutter, Richard Rudick, and NMSS Consortium
Aina	Clinician-rated	Clinician-administered performance test
Chanzo asilia	Goetz, C. G., et al. (2008). Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results. Movement Disorders, 23(15), 2129-2170.	Cutter, G. R., Baier, M. L., Rudick, R. A., et al. (1999). Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Multiple Sclerosis, 5(4), 244-250.
Majina mbadala	UPDRS	MS Functional Composite
Zinazohusiana	5	4
Muhtasari	The MDS-UPDRS is the gold-standard clinician-administered rating scale for assessing motor and non-motor manifestations of Parkinson's disease. Developed by the Movement Disorder Society in 2008 to enhance the original UPDRS, it measures disease severity across daily living, motor function, and treatment complications. Used globally in clinical trials, longitudinal cohort studies, and routine neurological practice.	The Multiple Sclerosis Functional Composite (MSFC) is an objective, performance-based assessment of MS-related disability capturing three key functional domains: lower extremity mobility, upper extremity coordination, and cognitive/processing speed. Developed in 1999 by the National MS Society and adopted widely in clinical trials, the MSFC provides quantifiable endpoints complementing the Expanded Disability Status Scale (EDSS). The three-component design addresses EDSS limitations by including cognition and standardizing measurement via timed tasks.